Evidence map›Paper›PMID 34637781›Full record

ArticleCell host & microbe2021

In vivo commensal control of Clostridioides difficile virulence.

Brintha P Girinathan, Nicholas DiBenedetto, Jay N Worley, Johann Peltier, Mario L Arrieta-Ortiz, Selva Rupa Christinal Immanuel, Richard Lavin, Mary L Delaney, Christopher K Cummins, Maria Hoffman and 9 more

Open access · greenAbstract read
In one paragraph

Article in Cell host & microbe, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 113 citations in OpenAlex.

  1. Review
  2. Article
  3. Optimized Surveillance Testing for ToxigenicmedRxiv : the preprint server for health sciences · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Clostridioides difficile pathogenesis and control.Nature reviews. Microbiology · 2026
    Review
  9. Article
  10. Article
  11. Review
  12. Gut microbes · 2025
    Article
  13. The emerging view on the roles of butyrate inInfection and immunity · 2025
    Review
  14. Article
  15. Systematic evaluation of metatranscriptomic differential gene expressionbioRxiv : the preprint server for biology · 2025
    Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 2 institutions in 1 country.

Brintha P GirinathanMassachusetts Host-Microbiome Center, Brigham & Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Nicholas DiBenedettoMassachusetts Host-Microbiome Center, Brigham & Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Jay N WorleyMassachusetts Host-Microbiome Center, Brigham & Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; National Center of Biotechnology Information, National Library of Medicine, Bethesda, MD 20894, USA.
Johann PeltierLaboratoire Pathogenèse des Bactéries Anaérobies, Institut Pasteur, UMR CNRS 2001, Université de Paris, 25-28 Rue du Dr. Roux, Institut Pasteur, 75015 Paris Cedex, France; Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Université Paris-Saclay, 91198, Gif-sur-yvette Cedex, France.
Mario L Arrieta-OrtizInstitute for Systems Biology, Seattle, WA 98109, USA.
Selva Rupa Christinal ImmanuelInstitute for Systems Biology, Seattle, WA 98109, USA.
Richard LavinMassachusetts Host-Microbiome Center, Brigham & Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Mary L DelaneyMassachusetts Host-Microbiome Center, Brigham & Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Clinical Microbiology Laboratory, Department of Pathology, Brigham & Women's Hospital, Boston, MA 02115, USA.
Christopher K CumminsMassachusetts Host-Microbiome Center, Brigham & Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Maria HoffmanCenter for Food Safety and Applied Nutrition, United States Food and Drug Administration, Department of Microbiology, College Park, MD 20740, USA.
Yan LuoCenter for Food Safety and Applied Nutrition, United States Food and Drug Administration, Department of Microbiology, College Park, MD 20740, USA.
Narjol Gonzalez-EscalonaCenter for Food Safety and Applied Nutrition, United States Food and Drug Administration, Department of Microbiology, College Park, MD 20740, USA.
Marc AllardCenter for Food Safety and Applied Nutrition, United States Food and Drug Administration, Department of Microbiology, College Park, MD 20740, USA.
Andrew B OnderdonkMassachusetts Host-Microbiome Center, Brigham & Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Clinical Microbiology Laboratory, Department of Pathology, Brigham & Women's Hospital, Boston, MA 02115, USA.
Georg K GerberMassachusetts Host-Microbiome Center, Brigham & Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Harvard-MIT Health Sciences & Technology, Cambridge, MA 02139, USA.
Abraham L SonensheinDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, MA 02111, USA.
Nitin S BaligaInstitute for Systems Biology, Seattle, WA 98109, USA.
Bruno DupuyLaboratoire Pathogenèse des Bactéries Anaérobies, Institut Pasteur, UMR CNRS 2001, Université de Paris, 25-28 Rue du Dr. Roux, Institut Pasteur, 75015 Paris Cedex, France.
Lynn BryMassachusetts Host-Microbiome Center, Brigham & Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Clinical Microbiology Laboratory, Department of Pathology, Brigham & Women's Hospital, Boston, MA 02115, USA. Electronic address: lbry@bwh.harvard.edu.
Institute for Systems Biology · USTufts University · US

Funding

STRUCTURE-FUNCTION RELATIONSHIPS IN THE ALIMENTARY TRACTP30DK034854 · NIDDK · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI JONATHAN C KAGAN · 1986 to 2026
$32.4M
Technology CoreU19AI106761 · NIAID · SEATTLE BIOMEDICAL RESEARCH INSTITUTE · PI SHERMAN, DAVID R, ZAK, DANIEL E · 2013 to 2017
$18.9M
Technology CoreU19AI135976 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI ADEREM, ALAN A · 2018 to 2022
$17.0M
VASCULAR, PULMONARY AND RENAL INJURYT32HL007627 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI GIMBRONE, MICHAEL A, MITCHELL, RICHARD N · 1985 to 2019
$12.7M
A systems analysis of drug tolerance in Mycobacterium tuberculosisR01AI128215 · NIAID · INSTITUTE FOR SYSTEMS BIOLOGY · PI Nitin S Baliga · 2017 to 2026
$8.8M
Site Specific Immunophenotyping Assays of COVID19 Patients to Align with NIAID National StudyR01AI141953 · NIAID · INSTITUTE FOR SYSTEMS BIOLOGY · PI BALIGA, NITIN S · 2019 to 2023
$5.7M
Commensal control of C. difficile virulenceR01AI153605 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI BRY, LYNN · 2021 to 2025
$3.4M
NHLBI NIH HHS T32 HL007627NIAID NIH HHS R01 AI128215NIAID NIH HHS R01 AI141953NIAID NIH HHS R01 AI153605NIAID NIH HHS U19 AI106761NIAID NIH HHS U19 AI135976NIDDK NIH HHS P30 DK034854
6 · The paper itself

Abstract

Leveraging systems biology approaches, we illustrate how metabolically distinct species of Clostridia protect against or worsen Clostridioides difficile infection in mice by modulating the pathogen's colonization, growth, and virulence to impact host survival. Gnotobiotic mice colonized with the amino acid fermenter Paraclostridium bifermentans survive infection with reduced disease severity, while mice colonized with the butyrate-producer, Clostridium sardiniense, succumb more rapidly. Systematic in vivo analyses revealed how each commensal alters the gut-nutrient environment to modulate the pathogen's metabolism, gene regulatory networks, and toxin production. Oral administration of P. bifermentans rescues conventional, clindamycin-treated mice from lethal C. difficile infection in a manner similar to that of monocolonized animals, thereby supporting the therapeutic potential of this commensal species. Our findings lay the foundation for mechanistically informed therapies to counter C. difficile disease using systems biology approaches to define host-commensal-pathogen interactions in vivo.

Indexed as

SymbiosisAmino AcidsAnimalsArginineButyratesCecumClostridioides difficileClostridiumClostridium InfectionsEubacterialesFermentationGene Expression ProfilingGene Expression Regulation, BacterialGene Regulatory NetworksGerm-Free LifeMiceAmino AcidsArginineButyratesanaerobe metabolismcarbon source enrichment analysisClostridioides difficileClostridium sardiniensecolitisconventional mousegnotobiotic mousemetabolomicsmetatranscriptomicsParaclostridium bifermentans

Identifiers

PMID34637781
PMCPMC8651146
OpenAlexW3207286353

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.